معرفی
Heidi Wehring, a board-certified psychiatric pharmacist, is an Adjunct Associate Professor of Psychiatry at the University of Maryland School of Medicine and affiliated with the Maryland Psychiatric Research Center. Her work bridges clinical research and treatment for serious mental illness across adult and pediatric populations.
- University of Iowa - BS in Psychology (1995)
- University of Iowa - PharmD in Pharmacy (2000)
- University of Maryland - Psychiatric Pharmacy Residency (2001)
- University of Maryland School of Medicine - Postdoctoral Psychiatry Fellowship (2011)
Dr. Wehring's research focuses on psychopharmacology, particularly for schizophrenia and pediatric mental health. She investigates treatment-resistant schizophrenia, antipsychotic effects on tobacco craving, and smoking cessation strategies in psychiatric populations.
Her recent publications highlight interdisciplinary approaches to schizophrenia treatment, with emphasis on pharmacokinetic interactions (minocycline-clozapine), behavioral addictions, and population-specific characteristics in smokers with schizophrenia. Awards include the H. McKee Jarboe Award (2012) and ACNP Travel Awardee (2014). As principal investigator for NIDA-funded research (K23 DA034034), she led a 5-year study on tobacco craving mechanisms.
- 2012 - H. McKee Jarboe Award for Mental Health Research
- 2014 - American College of Neuropsychopharmacology Travel Awardee
Based at the Maryland Psychiatric Research Center/Tawes Building, her work spans clinical trials, pharmacotherapy development, and educational initiatives for complex psychiatric disorders, particularly in dual diagnosis scenarios.
